ravani
Selected indexed studies
- Old and new oral anticoagulants: Food, herbal medicines and drug interactions. (Blood Rev, 2017) [PMID:28196633]
- Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial. (J Am Soc Nephrol, 2021) [PMID:33649098]
- Associations between hemodialysis access type and clinical outcomes: a systematic review. (J Am Soc Nephrol, 2013) [PMID:23431075]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Old and new oral anticoagulants: Food, herbal medicines and drug interactions. (2017) pubmed
- Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial. (2021) pubmed
- Associations between hemodialysis access type and clinical outcomes: a systematic review. (2013) pubmed
- Accounting for Age in the Definition of Chronic Kidney Disease. (2021) pubmed
- Predicting the risks of kidney failure and death in adults with moderate to severe chronic kidney disease: multinational, longitudinal, population based, cohort study. (2024) pubmed
- Atheroembolic renal disease. (2010) pubmed
- Regulation of mammalian cellular metabolism by endogenous cyanide production. (2025) pubmed
- Controversies in vascular access. (2018) pubmed
- CAR-T cell therapy for rheumatoid arthritis: current status and molecular insights. (2025) pubmed
- Immunosuppressive therapy for IgA nephropathy in children. (2024) pubmed